Botanical species · safety record

Peucedanum ostruthium

The EFSA Compendium of Botanicals holds 27 constituent measurements for Peucedanum ostruthium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Peucedanum ostruthium (L.) W.Koch.

27Constituent measurements

0Safety records

8Cited sources

2Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2 licensed products naming Peucedanum ostruthium as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Root

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Coumarins	Roots and other underground parts	Solvent extraction	≥ 16.47 Milligram/gram	HPLC-DAD	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	≤ 31.31 Milligram/gram	HPLC-DAD	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	≥ 5.28 Milligram/gram	HPLC-DAD	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	≤ 9.22 Milligram/gram	HPLC-DAD	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Furanocoumarins	Roots and other underground parts	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Imperatorin	Roots and other underground parts	Solvent extraction	≤ 14.27 Milligram/gram	HPLC-DAD	Resolve DOI
Imperatorin	Roots and other underground parts	Solvent extraction	≥ 4.88 Milligram/gram	HPLC-DAD	Resolve DOI
Isoimperatorin	Roots and other underground parts	Solvent extraction	≥ 3.96 Milligram/gram	HPLC-DAD	Resolve DOI
Isoimperatorin	Roots and other underground parts	Solvent extraction	≤ 6.99 Milligram/gram	HPLC-DAD	Resolve DOI
Osthol	Roots and other underground parts	Solvent extraction	≥ 0.25 Milligram/gram	HPLC-DAD	Resolve DOI
Osthol	Roots and other underground parts	Solvent extraction	≤ 8.81 Milligram/gram	HPLC-DAD	Resolve DOI
Oxypeucedanin	Roots and other underground parts	Solvent extraction	≤ 17.21 Milligram/gram	HPLC-DAD	Resolve DOI
Oxypeucedanin	Roots and other underground parts	Solvent extraction	≥ 6.91 Milligram/gram	HPLC-DAD	Resolve DOI
Oxypeucedanin hydrate	Roots and other underground parts	Solvent extraction	≥ 1.58 Milligram/gram	HPLC-DAD	Resolve DOI
Oxypeucedanin hydrate	Roots and other underground parts	Solvent extraction	≤ 3.93 Milligram/gram	HPLC-DAD	Resolve DOI
Peucenin	Roots and other underground parts	Solvent extraction	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
1,8-cineole	Unspecified	Essential oil	—	Gaschromatography (GC)	No resolvable identifier
Coumarins	Unspecified	—	—	Unspecified	No resolvable identifier
Furanocoumarins	Unspecified	—	—	Unspecified	No resolvable identifier
Myrcene	Roots and other underground parts	Essential oil	1.3 Percent	GC-MS	No resolvable identifier
Myrcene	Aerial part of plants	Essential oil	3.1 Percent	GC-MS	No resolvable identifier
Osthol	Roots and other underground parts	Essential oil	5.1 Percent	GC-MS	No resolvable identifier
Osthol	Aerial part of plants	Essential oil	5.5 Percent	GC-MS	No resolvable identifier
Oxypeucedanin	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Pabulenol	Unspecified	—	—	Unspecified	No resolvable identifier
Peucenin	Unspecified	—	—	Unspecified	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Cisowski, W., Sawicka, U., Mardarowicz, M., Asztemborska, M., Luczkiewicz, M. Essential oil from herb and rhizome of Peucedanum ostruthium (L. Koch.) ex DC. . Zeitschrift fur naturforschung c-a journal of biosciences, 2001, vol. 56, no. 11-12, p. 930-932.
Hethelyi, E. B., Galambosi, B., Szarka, S., Lemberkovics, E., Szoke, E. Phytochemical investigation of medicinal and culinary herbs. Acta agronomica hungarica, 2012, vol. 60, no. 3, p. 201-207.
REISCH, J., KHALED, SA., SZENDREI, K., NOVAK, I. NATURAL PRODUCT CHEMISTRY .51. 5-ALKOXY-FURANOCOUMARINS FROM PEUCEDANUM-OSTRUTHIUM . Phytochemistry, 1975, vol. 14, no. 8, p. 1889-1890. DOI
Vogl, Sylvia., Zehl, Martin., Picker, Paolo., Urban, Ernst., Wawrosch, Christoph., Reznicek, Gottfried., Saukel, Johannes., Kopp, Brigitte. Identification and Quantification of Coumarins in Peucedanum ostruthium (L.) Koch by HPLC-DAD and HPLC-DAD-MS . Journal of agricultural and food chemistry, 2011, vol. 59, no. 9, p. 4371-4377. DOI
Urbain, A., Marston, A., Hostettmann, K. Coumarins from Peucedanum ostruthium as inhibitors of acetylcholinesterase . Pharmaceutical biology, 2005, vol. 43, no. 8, p. 647-650. DOI
Hiermann, A., Schantl, D., SchubertZsilavecz, M., Reiner, J. Coumarins from Peucedanum ostruthium. Phytochemistry, 1996, vol. 43, no. 4, p. 881-883. DOI
Luszczki, Jarogniew J., Andres-Mach, Marta., Glensk, Michal., Skalicka-Wozniak, Krystyna. Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: a comparative study. PHARMACOLOGICAL REPORTS, 2010, vol. 62, no. 6, p. 1231-1236.
Varga, E., Simokovics, J., Szendrei, K., Reisch, J. Furanocoumarins and chromones from the fruits of Peucedanum ostrutbium L. (Koch) (Umbelliferae). Fitoterapia, 1979, vol. 50, no. 6, p. 259-64.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature